Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Virtual Event

Sep 28, 2020 2:00 PM - Sep 30, 2020 6:00 PM

(Central Europe Standard Time)

4051 Basel, Switzerland

Regulatory Science Forum

Session 7: Pharmacovigilance

Session Chair(s)

Helga  Gardarsdottir, FISPE

Helga Gardarsdottir, FISPE

Professor RWD for decision making on medicines, Utrecht University, Netherlands

Session 7: Pharmacovigilance

Speaker(s)

Florence  van Hunsel, PHARMD, PHD

Florence van Hunsel, PHARMD, PHD

Head Signal Detection, Netherlands Pharmacovigilance Centre Lareb, Netherlands

Signals from a national spontaneous reporting system; What regulatory action do they lead to?

Lotte  Minnema, MPHARM

Lotte Minnema, MPHARM

PhD candidate/pharmacovigilance assessor, Utrecht University/Medicines Evaluation Board, Netherlands

Do labels of drugs with the same mechanism of action describe the same adverse drug reactions? A case study on TNF-a inhibitors

Saad  Shakir, MD, FFPM, FISPE, FRCP

Saad Shakir, MD, FFPM, FISPE, FRCP

Pharmacovigilance Physician and Pharmacoepidemiologist, ADROITVIGILANCE, United Kingdom

The Quality and Robustness of Evidence used to support Regulatory Pharmacovigilance Decisions

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.